Sponsor Pipeline

Shenzhen University General Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
11
Active Trials
10
Recruiting
8
Disease Areas
Active Trials by Phase
Phase 2
2
Phase 1/2
5
Not specified
4
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07563179 Bugitinib Combined With Venetoclax and Cytarabine in Relapsed/Refractory Acute Myeloid… Acute Myeloid Leukemia Recruiting
NCT06234072 Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for… Pancreatic Cancer Not Yet Recruiting
Phase 1/2
NCT06644443 BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma Multiple Myeloma in Relapse Recruiting
NCT07097207 Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma Relapsed/Refractory B-cell Lymphoma Recruiting
NCT07399769 Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors Advanced Solid Malignant Tumors (With Positive Expression of MSLN in Tumor Tissue) Recruiting
NCT07508605 Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma Relapsed/Refractory B-cell Lymphoma Recruiting
NCT07584889 Efficacy and Safety of CD19-CAR.p40-T in Patients With Relapsed/Refractory CD19-Positive… B Cell Lymphoma Recruiting
Not specified
NCT05620680 CD7 CAR-T Cells in T-cell Lymphoma/Leukemia T Lymphoblastic Leukemia/Lymphoma Recruiting
NCT05620693 Study of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma Advanced Soft-tissue Sarcoma Recruiting
NCT05620706 Study of GPC-3 CAR-T Cells in Treating With Hepatocellular Carcinoma Advanced Hepatocellular Carcinoma Recruiting
NCT05620732 Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T Advanced Pancreatic Carcinoma Recruiting
Disease Areas
Get alerts when Shenzhen University General Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free